ADVANZ PHARMA Corp. Limited
ADVANZ PHARMA Corp. Limited, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of specialty and generic medicines. Founded in 2018, the company has rapidly established itself across key operational regions, including Europe and North America, focusing on therapeutic areas such as oncology, neurology, and infectious diseases. With a commitment to providing high-quality, accessible healthcare solutions, ADVANZ PHARMA offers a diverse portfolio of products that stand out for their efficacy and safety. The company has achieved significant milestones, including strategic partnerships and a growing market presence, positioning itself as a trusted provider in the pharmaceutical landscape. Through innovation and a patient-centric approach, ADVANZ PHARMA continues to enhance its reputation and impact within the healthcare sector.
DitchCarbon Score
How does ADVANZ PHARMA Corp. Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ADVANZ PHARMA Corp. Limited's score of 25 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ADVANZ PHARMA Corp. Limited's reported carbon emissions
ADVANZ PHARMA Corp. Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented reduction targets or climate commitments available from the company. As of now, ADVANZ PHARMA has not inherited any emissions data from a parent or related organization, nor does it have any cascading climate initiatives from other entities. This lack of data suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. In the broader context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction initiatives. However, without specific commitments or data from ADVANZ PHARMA, it is challenging to assess their position relative to industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ADVANZ PHARMA Corp. Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
